… RT in head and neck cancer patients and in patients receiving high-dose chemotherapy…
patients undergoing bone marrow transplantation. No guideline was possible for any other agent …

… OM in head and neck (H&N) cancer patients receiving radiotherapy with concomitant … )
patients was re-established. A previous Suggestion for zinc to prevent OM in H&N cancer patients …

… of OM in patients undergoing HSCT. No guideline was possible for any other agents [5,6].
The … evidence for the efficacy of natural and miscellaneous agents for the prevention and/or …

… miscellaneous new agents at this year's meeting, several described novel cytotoxics and
hormonal agents… responses were seen in patients with non–small-cell lung cancer (NSCLC). …

… Sequist presented the early findings of a phase I study evaluating OPB51602 in patients
with advanced cancer. This drug inhibits the phosphorylation of STAT-3, preventing its …

… This review and meta-analysis on natural and miscellaneous agents in preventing RD in
cancer patients demonstrated that oral enzymes and olive oil prevented RD severity. However, …

… A previous Suggestion for zinc to prevent OM in H&N cancer patients treated with … glutamine
in HSCT patients and a Suggestion in favor of oral glutamine in H&N cancer patients for the …

… This chapter focuses on various agents that are used against solid and hematopoietic
tumors through distinct mechanisms of action. l-asparaginase catalyzes the conversion of l-…

… It is recommended that sensorineural deafness in selected patients with otosclerosis should
be treated with sodium fluoride. Also, patients with Paget's disease treated with APD must …

… Many chemicals which are present as industrial or environmental pollutants, dietary
components, combustion by-products or therapeutic agents may increase the risk of cancer …